Abstract:Chemotherapy resistance to glioblastoma (GBM) remains an obstacle that is difficult to overcome, leading to poor prognosis of GBM patients. Many previous studies have focused on resistance mechanisms intrinsic to cancer cells; the microenvironment surrounding tumor cells has been found more recently to have significant impacts on the response to chemotherapeutic agents. Extracellular matrix (ECM) proteins may confer cell adhesion-mediated drug resistance (CAMDR). Here, expression of the ECM proteins laminin, vitronectin, and fibronectin was assessed in clinical GBM tumors using immunohistochemistry. Then, patient-derived GBM cells grown in monolayers on precoated laminin, vitronectin, or fibronectin substrates were treated with cilengitide, an integrin inhibitor, and/or carmustine, an alkylating chemotherapy. Cell adhesion and viability were quantified. Transcription factor (TF) activities were assessed over time using a bioluminescent assay in which GBM cells were transduced with lentiviruses containing consensus binding sites for specific TFs linked to expression a firefly luciferase reporter. Apoptosis, mediated by p53, was analyzed by Western blotting and immunocytofluorescence. Integrin α v activation of the FAK/paxillin/AKT signaling pathway and effects on expression of the proliferative marker Ki67 were investigated. To assess effects of integrin α v activation of AKT and ERK pathways, which are typically deregulated in GBM, and expression of epidermal growth factor receptor (EGFR), which is amplified and/or mutated in many GBM tumors, shRNA knockdown was used. Laminin, vitronectin, and fibronectin were abundant in clinical GBM tumors and promoted CAMDR in GBM cells cultured on precoated substrates. Cilengitide treatment induced cell detachment, which was most pronounced for cells cultured on vitronectin. Cilengitide treatment increased cytotoxicity of carmustine, reversing CAMDR. ECM adhesion increased activity of NFκB and decreased that of p53, leading to suppression of p53-mediated apoptosis and upregulation of multidrug resistance gene 1 (MDR1; also known as ABCB1 or P-glycoprotein). Expression of Ki67 was correlative with activation of the integrin α v -mediated FAK/paxillin/AKT signaling pathway. EGFR expression increased with integrin α v knockdown GBM cells and may represent a compensatory survival mechanism. These results indicate that ECM proteins confer CAMDR through integrin α v in GBM cells.

Lamins regulate nuclear mechanics and shape to control glioblastoma cell proliferation, migration and invasion

Laminin Alpha 2 Enables Glioblastoma Stem Cell Growth

Hmga2 Sustains Self-Renewal and Invasiveness of Glioma-Initiating Cells

Lamin B2 follows lamin A/C- mediated nuclear mechanics and cancer cell invasion efficacy

Impact of Nuclear Peripheral Chromatin Lamin LMNB1 Gene in the Proliferation and Migration of Glioma Cells

Lamin B1 Deficiency Promotes Malignancy and Predicts Poor Prognosis in Gastric Cancer.

Low lamin A levels enhance confined cell migration and metastatic capacity in breast cancer

Association Between Laminin Γ1 Expression and Meningioma Grade, Recurrence, and Progression-Free Survival

METTL1-modulated LSM14A facilitates proliferation and migration in glioblastoma via the stabilization of DDX5

Functions of lamin B1 and the new progress of its roles in neurological diseases and tumors

Lamin B1 Overexpression Promotes Breast Cancer Growth Via Increasing H3K9ac Modification Through HDAC2 Inhibition

MiR-124-5p Inhibits the Growth of High-Grade Gliomas Through Posttranscriptional Regulation of LAMB1.

Elevated Invasive Potential of Glioblastoma Stem Cells.

Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis

Extracellular Matrix Proteins Confer Cell Adhesion-Mediated Drug Resistance Through Integrin αv in Glioblastoma Cells

LEF1 Regulates Glioblastoma Cell Proliferation, Migration, Invasion, and Cancer Stem-Like Cell Self-Renewal

Mechanism and role of nuclear laminin B1 in cell senescence and malignant tumors

Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells Via AKT Pathway.

Biomechanical properties of laminins and their impact on cancer progression

Lamin B2 promotes the malignant phenotype of non-small cell lung cancer cells by upregulating dimethylation of histone 3 lysine 9